NK cell‐mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites
- 1 October 1996
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 57 (4), 312-319
- https://doi.org/10.1111/j.1600-0609.1996.tb01383.x
Abstract
Blasts recovered from patients with acute myelogenous leukaemia (AML) were lysed by heterologous natural killer (NK) cells treated with NK cell-activating cytokines such as interleukin-2 (IL-2) or interferon-α (IFN-α). The cytokine-induced killing of AML blasts was inhibited by monocytes, recovered from peripheral blood by counterflow centrifugal elutriation. Histamine, at concentrations exceeding 0.1 μM, abrogated the monocyte-induced inhibition of NK cells; thereby, histamine and IL-2 or histamine and IFN-α synergistically induced NK cell-mediated destruction of AML blasts. The effect of histamine was completely blocked by the histamine H2-receptor (H2R) antagonist ranitidine but not by its chemical control AH20399AA. Catalase, a scavenger of reactive oxygen metabolites (ROM), reversed the monocyte-induced inhibition of NK cell-mediated killing of blast cells, indicating that the inhibitory signal was mediated by products of the respiratory burst of monocytes. It is concluded that (i) monocytes inhibit anti-leukemic properties of NK cells, (ii) the inhibition is conveyed by monocyte-derived ROM, and (iii) histamine reverses the inhibitory signal and, thereby, synergizes with NK cell-activating cytokines to induce killing of AML blasts.Keywords
This publication has 16 references indexed in Scilit:
- Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot studyBritish Journal of Haematology, 2008
- Histaminergic Regulation of NK‐Cells: Protection Against Monocyte‐Induced ApoptosisScandinavian Journal of Immunology, 1996
- Histaminergic regulation of interferon-gamma (IFN-γ) production by human natural killer (NK) cellsClinical and Experimental Immunology, 1996
- Remission maintenance therapy with histamine and interleukin‐2 in acute myelogenous leukaemiaBritish Journal of Haematology, 1996
- Histaminergic Regulation of Natural Killer Cell‐Mediated Clearance of Tumour Cells in MiceScandinavian Journal of Immunology, 1996
- Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites.The Journal of Immunology, 1996
- Cell‐to‐Cell Mediated Inhibition of Natural Killer Cell Proliferation by Monocytes and its Regulation by Histamine H2‐ReceptorsScandinavian Journal of Immunology, 1991
- Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevanceBritish Journal of Haematology, 1991
- Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: A pilot studyLeukemia Research, 1990
- Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.The Journal of Immunology, 1987